Loading...

PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg £50
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg £126
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  4. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  5. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  6. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  7. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  8. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  9. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  10. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  11. Du Y, et al. 2022. J Exp Med. 219: . PubMed
  12. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  13. Marquardt RM, et al. 2022. Int J Mol Sci. 23: . PubMed
  14. Zhao Z, et al. 2022. Adv Sci (Weinh). 9:e2201293. PubMed
  15. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  16. Zhang Z, et al. 2022. Mol Nutr Food Res. 66:e2200300. PubMed
  17. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  18. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  19. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  20. Guo R, et al. 2022. Cells. 12: . PubMed
  21. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  22. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  23. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  24. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  25. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  26. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  27. Harapas CR, et al. 2022. Sci Immunol. 7:eabi4611. PubMed
  28. Boroumand P, et al. 2022. Elife. 11:. PubMed
  29. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  30. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  31. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  32. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  33. Yin C, et al. 2023. Sci Rep. 13:3903. PubMed
  34. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  35. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  36. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  37. Hsieh MS, et al. 2023. NPJ Vaccines. 8:82. PubMed
  38. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  39. Tseng JC, et al. 2023. Int J Biol Sci. 19:2648. PubMed
  40. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  41. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  42. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  43. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  44. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  45. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  46. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  47. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  48. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  49. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  50. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  51. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  52. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  53. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  54. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  55. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  56. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  57. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  58. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  59. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  60. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  61. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  62. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  63. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  64. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  65. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  66. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  67. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  68. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  69. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  70. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  71. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  72. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  73. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  74. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  75. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  76. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  77. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  78. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  79. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  80. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  81. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  82. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  83. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  84. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  85. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  86. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  87. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  88. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  89. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  90. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  91. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  92. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  93. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  94. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  95. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  96. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  97. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  98. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  99. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  100. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  101. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  102. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  103. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  104. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  105. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  106. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  107. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  108. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  109. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  110. De Simone G, et al. 2021. Immunity. :. PubMed
  111. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  112. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  113. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  114. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  115. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  116. Vorselen D, et al. 2021. Elife. 10:. PubMed
  117. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  118. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  119. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  120. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  121. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  122. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  123. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  124. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  125. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  126. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  127. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  128. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  129. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  130. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  131. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  132. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  133. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  134. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  135. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  136. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  137. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  138. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  139. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  140. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  141. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  142. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  143. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  144. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  145. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  146. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  147. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  148. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  149. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  150. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  151. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  152. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  153. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  154. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  155. Gu H, et al. 2021. Elife. 10:. PubMed
  156. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  157. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  158. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  159. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  160. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  161. Bussey KA, et al. 2019. J Virol. 93. PubMed
  162. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  163. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  164. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  165. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  166. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  167. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  168. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  169. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  170. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  171. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  172. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  173. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  174. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  175. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  176. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  177. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  178. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  179. Jones GS, et al. 2020. mSphere. 5:. PubMed
  180. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  181. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  182. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  183. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  184. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  185. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  186. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  187. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  188. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  189. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  190. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  191. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  192. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV™ 395 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account